RxDoctor Payments Data

Kerry McGonagle

Adult Health · Alexandria, VANPI 1932575743

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,458, 3.3 times the $446 reported in 2022.

$3,619in general payments, 2019–2025

Across 157 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$698
  • Janssen Scientific Affairs, LLC$623
  • AbbVie$555
  • Takeda Pharmaceuticals U.S.A., Inc.$413
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$246
  • Sanofi$184
  • plus $901 from 18 others

What the payments were for

  • Food & beverage$3,56899%
  • Education$511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,619 in reported general payments places this provider in the 85th percentile of 368 adult health providers in Virginia.

See all adult health providers in Virginia

Medicare billing

Part B allowed, 2024
$1,958
Medicare patients
17
Services billed
28

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates46$2,620
Omeprazole40$789
Esomeprazole Magnesium15$529
Pantoprazole Sodium20$309
Famotidine16$299
Dicyclomine Hcl11$183
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl12$181

Paid to pharmacies, not to this prescriber.

Other adult health in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →